Puma Biotechnology

Puma Biotechnology(PBYI)

Puma Biotechnology is a publicly traded biopharmaceutical company (NASDAQ: PBYI) headquartered in Los Angeles, CA.

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

*Currency in USD

Company Revenue

Quarterly

Annual

Projections

*Quarterly sales USD (in millions)

Mock data
Subscribe for the real data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Nerlynx	Neratinib	2017-07-17	2025-2031	Breast neoplasms

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

Neratinib

healthy volunteers/patients

myelodysplastic syndromes

myeloid leukemia acute

hematologic neoplasms

pancreatic neoplasms

myeloproliferative disorders

non-hodgkin lymphoma

primary myelofibrosis

multiple myeloma

precursor cell lymphoblastic leukemia-lymphoma

b-cell chronic lymphocytic leukemia

bcr-abl positive chronic myelogenous leukemia

myelomonocytic leukemia chronic

anemia

hodgkin disease

leukemia myeloid chronic atypical bcr-abl negative

myelodysplastic-myeloproliferative diseases

myeloid leukemia chronic-phase

myeloid leukemia accelerated phase

ovarian epithelial carcinoma

liver failure

hepatic insufficiency

esophageal neoplasms

gastrointestinal neoplasms

esophageal squamous cell carcinoma

neoplasms

neoplasm metastasis

triple negative breast neoplasms

brain neoplasms

stomach neoplasms

non-small-cell lung carcinoma

adenocarcinoma

prostatic neoplasms

castration-resistant prostatic neoplasms

inflammatory breast neoplasms

hereditary sensory and autonomic neuropathies

central nervous system neoplasms

nervous system neoplasms

endometrial neoplasms

fallopian tube neoplasms

lobular carcinoma

invasive hydatidiform mole

pancreatic ductal carcinoma

ductal carcinoma

myoepithelioma

radiotherapy

adenosquamous carcinoma

breast neoplasms

recurrence

biliary tract neoplasms

uterine cervical neoplasms

urinary bladder neoplasms

neoadjuvant therapy

Benzimidazole

erectile dysfunction

Aglatimagene besadenovec

leiomyoma

myofibroma

head and neck neoplasms

esophageal neoplasms

disease progression

neuroendocrine carcinoma

castration-resistant prostatic neoplasms

adenocarcinoma

carcinoma

large b-cell lymphoma diffuse

urogenital neoplasms

male genital neoplasms

lymphoma

small cell lung carcinoma

renal cell carcinoma

male genital diseases

myelomonocytic leukemia chronic

systemic mastocytosis

myelomonocytic leukemia juvenile

hypereosinophilic syndrome

mastocytosis

dermatofibrosarcoma

hematologic neoplasms

sarcoma

b-cell lymphoma

neuroendocrine tumors

renal insufficiency

urologic neoplasms

kidney neoplasms

endometrial neoplasms

t-cell lymphoma

malignant mesothelioma

clear cell adenocarcinoma

x-linked bulbo-spinal atrophy

second primary neoplasms

plasma cell neoplasms

pancreatic ductal carcinoma

pancreatic neoplasms

neoplasms

acinar cell carcinoma

myeloid leukemia acute

Edrecolomab

myelodysplastic syndromes

preleukemia

syndrome

large b-cell lymphoma diffuse

b-cell chronic lymphocytic leukemia

lymphoid leukemia

lung neoplasms

small cell lung carcinoma

neuroendocrine carcinoma

newborn respiratory distress syndrome

primary myelofibrosis

healthy volunteers/patients

uterine cervical neoplasms

central nervous system neoplasms

nervous system neoplasms

triple negative breast neoplasms

b-cell lymphoma

large b-cell lymphoma diffuse

hepatocellular carcinoma

b-cell chronic lymphocytic leukemia

leukemia

small cell lung carcinoma

ductal carcinoma breast

macular degeneration

edema

renal cell carcinoma

fallopian tube neoplasms

peritoneal neoplasms

urinary bladder neoplasms

glioblastoma

head and neck neoplasms

asthma

sclerosis

lymphoid leukemia

mucinous adenocarcinoma

inflammatory breast neoplasms

paroxysmal hemoglobinuria

transitional cell carcinoma

retinal vein occlusion

crohn disease

schizophrenia

atypical hemolytic uremic syndrome

fibrosis

idiopathic pulmonary fibrosis

pulmonary fibrosis

autistic disorder

autism spectrum disorder

pervasive child development disorders

geographic atrophy

atrophy

systemic lupus erythematosus

nephrotic syndrome

ovarian epithelial carcinoma

brain neoplasms

esophageal squamous cell carcinoma

esophageal neoplasms

castration-resistant prostatic neoplasms

neuroendocrine carcinoma

papillary thyroid cancer

thyroid diseases

disease progression

recurrence

endometrioid carcinoma

arteritis

giant cell arteritis

polymyalgia rheumatica

type 2 diabetes mellitus

diabetes mellitus

membranous glomerulonephritis

multiple sclerosis

chronic progressive multiple sclerosis

ankylosing spondylitis

spondylarthritis

spondylitis

myeloid leukemia acute

myeloid leukemia

alzheimer disease

coronary disease

acute coronary syndrome

coronary artery disease

myocardial ischemia

heart diseases

relapsing-remitting multiple sclerosis

guillain-barre syndrome

autoimmune diseases of the nervous system

bcr-abl positive chronic myelogenous leukemia

circulating neoplastic cells

disability evaluation

cognition disorders

cytomegalovirus infections

anemia

hemolysis

hemolytic anemia autoimmune

focal segmental glomerulosclerosis

lipoid nephrosis

endometrial neoplasms

covid-19

graft rejection

retinal neovascularization

human influenza

type 3 von willebrand disease

breast neoplasms

non-small-cell lung carcinoma

lung neoplasms

adenocarcinoma

adenocarcinoma of lung

osteoporosis

postmenopausal osteoporosis

newborn respiratory distress syndrome